Biosimilars are making an impact in the GI field. Dr. Jennifer Caudle and Dr. Stephen Hanauer discuss the evolving role of biosimilars in anti-inflammatory care for GI patients.
Trending
- Exact Sciences and Lil Jon Partner on “Get Low #2” Campaign to Encourage Colon Cancer Screening (Business Wire)
- AI Tool Identifies Undiagnosed Early-Stage MASLD (MDedge)
- Joining forces to develop a multidisciplinary care model in GI (Takeda)
- Zepbound sheds more weight than Wegovy in trial, Eli Lilly says (NBC News)
- Cheap, non-invasive tool that detects bowel disease coming in 2027: Hong Kong scientists (South China Morning Post)
- Some Older Adults Think Stopping CRC Screening at Age 75 Is ‘Unacceptable’ (MedPage Today)
- Why Operators Are Embracing Hybrid ASC, Office-Based Lab Models (ASC News)
- This year, be thankful for AI in medicine (The Washington Post)
